Rebekah Karns

Title: Rebekah Karns: Innovator in Predictive Clinical Assays

Introduction

Rebekah Karns is a prominent inventor based in Cincinnati, OH. She has made significant contributions to the field of medical technology, particularly in the development of predictive clinical assays. Her work focuses on improving treatment outcomes for individuals at risk for negative consequences associated with various diseases.

Latest Patents

Rebekah Karns holds a patent for "Predictive clinical assays and methods of using same." This innovative patent discloses methods for treating individuals at risk for negative outcomes related to treatments for diseases, especially proliferative disorders like cancer. The method involves creating a predictive assay that incorporates both a biomarker and a genetic mutation. This predictive assay helps indicate the likelihood of adverse outcomes associated with specific treatments, allowing for more tailored and safer treatment options for patients.

Career Highlights

Karns is affiliated with the Children's Hospital Medical Center, where she applies her expertise in clinical research and innovation. Her work has been instrumental in advancing the understanding of how genetic factors can influence treatment efficacy and safety.

Collaborations

Throughout her career, Rebekah has collaborated with notable colleagues, including John Perentesis and Bruce Aronow. These partnerships have further enhanced her research and contributed to the development of groundbreaking medical technologies.

Conclusion

Rebekah Karns is a trailblazer in the field of predictive clinical assays, with a focus on improving patient outcomes through innovative methods. Her contributions to medical technology are paving the way for more personalized and effective treatments in the healthcare industry.